Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.

about

Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.Performance of the UroVysion® FISH assay for the diagnosis of malignant effusions using two cutoff strategies.

P2860

Q50350314-3F72EA2A-C68F-4C3E-911D-03D16555D0B5 Q52724204-8D18E8C5-0CD0-49BE-9478-E94978D55226

P2860

Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.

Item

http://www.wikidata.org/entity/Q42117021

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.

@en

Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.

@nl

type

Item

label

Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.

@en

Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.

@nl

prefLabel

Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.

@en

Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.

@nl

P1476

Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.

@en

P2093

Andrea Treszl

http://www.w3.org/2001/XMLSchema#string

Eva Sipos

http://www.w3.org/2001/XMLSchema#string

Gabor Mehes

http://www.w3.org/2001/XMLSchema#string

Gabor Olah

http://www.w3.org/2001/XMLSchema#string

Kata Hegyi

http://www.w3.org/2001/XMLSchema#string

Klara Fodor

http://www.w3.org/2001/XMLSchema#string

Lorant Szekvolgyi

http://www.w3.org/2001/XMLSchema#string

Nikoletta Dobos

http://www.w3.org/2001/XMLSchema#string

Zita Steiber

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death

Proteomics of uveal melanoma: a minireview

Distinct phenotypic differences associated with differential amplification of receptor tyrosine kinase genes at 4q12 in glioblastoma.

Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis.

Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats.

Does ocular treatment of uveal melanoma influence survival?

Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH.

Hypothalamic hormones and cancer.

Phase I, dose-escalation study of the targeted cytotoxic LHRH analog AEZS-108 in patients with castration- and taxane-resistant prostate cancer.

Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.

P304

1927-1934

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OR.2017.5496

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrew Schally

Gabor Halmos

P577

2017-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28350068

http://www.w3.org/2001/XMLSchema#string

P932

5367339

http://www.w3.org/2001/XMLSchema#string

Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.

about

P2860

P2860

Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932